Accelerating personalized medicine.

ApoCell collaborates with clients to co-develop assays based on biomarkers used in clinical research. In some trials of targeted agents, positive correlation between biomarker expression and clinical outcome has been demonstrated, forming the basis for IVD and laboratory based test development.

ApoCell is very experienced in developing and using sensitive and specific blood-based assays of target expression in circulating tumor and endothelial cells for clinical trials. This proven methodology can be adapted to diagnostic, prognostic and monitoring tests.